Back to Previous Page

Retigabine analytical standard

ITEM#: 3042-9022125MG

MFR#: 90221-25MG

Retigabine is an antiepileptic drug, which activates neuronal KCNQ-type K+ channels by inducing a large hyperpolarizing shift of steady-state activation.

See More Details
Retigabine is an antiepileptic drug, which activates neuronal KCNQ-type K+ channels by inducing a large hyperpolarizing shift of steady-state activation.
Provide Content Correction
Product Name Description Item# QTY
Manufacturer Default Logo Retigabine solution . Retigabine solution 3042-R0181ML EA
Retigabine >=98% (HPLC) Retigabine >=98% (HPLC) 3042-SML032550MG EA
Retigabine >=98% (HPLC) Retigabine >=98% (HPLC) 3042-SML032510MG EA
Manufacturer Default Logo Puerarin analytical standard Puerarin analytical standard 3042-9600610MG EA
Manufacturer Default Logo Hesperetin analytical standard Hesperetin analytical standard 3042-H412510G EA
Manufacturer Default Logo (-)-Bilobalide analytical standard (-)-Bilobalide analytical standard 3042-7959310MG EA
Manufacturer Default Logo Physcion analytical standard Physcion analytical standard 3042-9389310MG EA
Manufacturer Default Logo Fluoranthene analytical standard Fluoranthene analytical standard 3042-45504250MG EA
Manufacturer Default Logo Diflunisal analytical standard . Diflunisal analytical standard 3042-D32815G EA
Thank you for visiting. We look forward to serving you!

Read more about us:  Franklin Young Value



For Government, Military, Education and Government Prime Access:


New Customers Existing Customers

Please contact Customer Service with your questions.

Thank you for visiting, your account is pending approval.

You will received email notification for approval within 24hrs.

Contact customerservice@franklinyoung.com for any questions.

Thank you for requesting an account with Franklin Young.

Your request has been declined

We restrict website access to government entities, and related customers.

Please contact customerservice@franklinyoung.com with any questions.